Akzo Nobel N.V.
AKZOF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,989 | $2,626 | $2,613 | $2,619 |
| % Growth | 13.8% | 0.5% | -0.2% | – |
| Cost of Goods Sold | $1,784 | $1,588 | $1,565 | $1,593 |
| Gross Profit | $1,205 | $1,038 | $1,048 | $1,026 |
| % Margin | 40.3% | 39.5% | 40.1% | 39.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $826 | $855 | $898 |
| SG&A Expenses | $872 | $826 | $855 | $898 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$2 | $1 | $1 |
| Operating Expenses | $872 | $824 | $856 | $899 |
| Operating Income | $333 | $214 | $192 | $127 |
| % Margin | 11.2% | 8.1% | 7.3% | 4.8% |
| Other Income/Exp. Net | -$446 | -$35 | -$23 | -$32 |
| Pre-Tax Income | -$113 | $179 | $169 | $95 |
| Tax Expense | $110 | $44 | $48 | $59 |
| Net Income | -$228 | $124 | $107 | $21 |
| % Margin | -7.6% | 4.7% | 4.1% | 0.8% |
| EPS | -1.33 | 0.73 | 0.63 | 0.12 |
| % Growth | -282.2% | 15.9% | 425% | – |
| EPS Diluted | -1.33 | 0.72 | 0.62 | 0.12 |
| Weighted Avg Shares Out | 171 | 171 | 171 | 171 |
| Weighted Avg Shares Out Dil | 171 | 172 | 173 | 171 |
| Supplemental Information | – | – | – | – |
| Interest Income | $14 | $18 | $0 | $0 |
| Interest Expense | $53 | $68 | $30 | $36 |
| Depreciation & Amortization | $110 | $92 | $94 | $94 |
| EBITDA | $40 | $339 | $293 | $225 |
| % Margin | 1.3% | 12.9% | 11.2% | 8.6% |